These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3956160)

  • 1. Rat coagulation factor V purification and production of the monospecific antiserum.
    Cornillon B; Paul J; Mazzorana M; Belleville J
    Comp Biochem Physiol B; 1986; 83(2):397-401. PubMed ID: 3956160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.
    Chiu HC; Whitaker E; Colman RW
    J Clin Invest; 1983 Aug; 72(2):493-503. PubMed ID: 6348091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alternative complement pathway in chickens. Purification of factor B and production of a monospecific antibody against it.
    Koch C
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):253-9. PubMed ID: 3646826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure.
    Smith CM; Hanahan DJ
    Biochemistry; 1976 May; 15(9):1830-8. PubMed ID: 1268197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preparation and properties of factor V from bovine plasma.
    Chulkova T; Hernandez G
    Clin Chim Acta; 1975 Jul; 62(1):21-8. PubMed ID: 1149279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a contaminant protein in the purification of human factor V. Comparison of two purification methods.
    Bruin T; Ockelford P; ten Cate JW; Sturk A; Breederveld C
    Biochim Biophys Acta; 1983 Oct; 748(1):139-42. PubMed ID: 6615848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of human coagulation factor V.
    Kane WH; Majerus PW
    J Biol Chem; 1981 Jan; 256(2):1002-7. PubMed ID: 7451453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of L-glutamate decarboxylase from rabbit brain and preparation of a monospecific antiserum.
    Brandon C
    J Neurosci Res; 1986; 15(3):367-81. PubMed ID: 2422389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of functional human coagulation factor V by using a hybridoma antibody.
    Katzmann JA; Nesheim ME; Hibbard LS; Mann KG
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):162-6. PubMed ID: 6941242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of the phosphate/hydroxyl ion antiport protein from rat liver mitochondria.
    Gibb GM; Reid GP; Lindsay JG
    Biochem J; 1986 Sep; 238(2):543-51. PubMed ID: 3026356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and study of an acquired inhibitor of human coagulation factor V.
    Nesheim ME; Nichols WL; Cole TL; Houston JG; Schenk RB; Mann KG; Bowie EJ
    J Clin Invest; 1986 Feb; 77(2):405-15. PubMed ID: 3944265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical studies of factor V of bovine platelets.
    Ittyerah TR; Rawala R; Colman RW
    Eur J Biochem; 1981 Nov; 120(2):235-41. PubMed ID: 7032911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.
    Rapaport SI; Zivelin A; Minow RA; Hunter CS; Donnelly K
    Am J Clin Pathol; 1992 Jan; 97(1):84-91. PubMed ID: 1728869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of uteroglobin using monospecific antibodies coupled to divinylsulphone-activated agarose.
    Dannhorn DR; Wirth B; Kirchner C
    J Immunol Methods; 1989 May; 119(2):223-30. PubMed ID: 2723440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor V exists uncomplexed in bovine plasma.
    Ittyerah TR; Rawala R; Colman RW
    Biochim Biophys Acta; 1982 Feb; 714(3):524-9. PubMed ID: 6800411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of the monospecific antiserum directed to the ninth component of human complement (C9).
    Kawachi-Takahashi S; Tanaka K; Takahashi M
    Jpn J Exp Med; 1974 Jun; 44(3):283-90. PubMed ID: 4215913
    [No Abstract]   [Full Text] [Related]  

  • 19. Tryptophan 5-hydroxylase. Rapid purification from whole rat brain and production of a specific antiserum.
    Cash CD; Vayer P; Mandel P; Maitre M
    Eur J Biochem; 1985 Jun; 149(2):239-45. PubMed ID: 3996408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical studies on factor V.
    Greenquist AC; Weinberg RM; Kuo AL; Colman RW
    Eur J Biochem; 1975 Oct; 58(1):213-22. PubMed ID: 810349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.